The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models (Q73446057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

fludarabine phosphate

1 reference

1 reference

R Or

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Weiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Amir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Tejman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Polliack

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

263-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10673697%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702107

4 November 2019

exact match

0 references

cites work

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Cytokine dysregulation as a mechanism of graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Severe immunodeficiency in patients treated with fludarabine monophosphate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Potential Immunological Action of Purine Nucleoside Analogues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Purine nucleoside modulation of functions of human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021

Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702107

7 January 2021